Web Analytics

3 Latest Announced Rounds

$1,738.89M Raised in 75 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Deverra Therapeutics

start up
United States - Seattle
  • 20/09/2023
  • Unknown
  • $2,400,000

Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.


Related People

Colleen DelaneyFounder

Colleen Delaney United States - Seattle, Washington,

N/A